![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FAT2 |
Gene summary for FAT2 |
![]() |
Gene information | Species | Human | Gene symbol | FAT2 | Gene ID | 2196 |
Gene name | FAT atypical cadherin 2 | |
Gene Alias | CDHF8 | |
Cytomap | 5q33.1 | |
Gene Type | protein-coding | GO ID | GO:0001667 | UniProtAcc | Q6PIA2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2196 | FAT2 | CCI_1 | Human | Cervix | CC | 1.74e-04 | 6.34e-01 | 0.528 |
2196 | FAT2 | CCI_2 | Human | Cervix | CC | 1.15e-11 | 1.27e+00 | 0.5249 |
2196 | FAT2 | CCI_3 | Human | Cervix | CC | 3.53e-29 | 1.83e+00 | 0.516 |
2196 | FAT2 | sample3 | Human | Cervix | CC | 9.92e-05 | 2.12e-01 | 0.1387 |
2196 | FAT2 | T3 | Human | Cervix | CC | 4.61e-04 | 2.04e-01 | 0.1389 |
2196 | FAT2 | LZE4T | Human | Esophagus | ESCC | 9.89e-08 | 3.20e-01 | 0.0811 |
2196 | FAT2 | LZE8T | Human | Esophagus | ESCC | 1.14e-16 | 5.91e-01 | 0.067 |
2196 | FAT2 | P2T-E | Human | Esophagus | ESCC | 3.84e-14 | 4.48e-01 | 0.1177 |
2196 | FAT2 | P4T-E | Human | Esophagus | ESCC | 5.26e-04 | 1.43e-01 | 0.1323 |
2196 | FAT2 | P5T-E | Human | Esophagus | ESCC | 1.87e-11 | 3.16e-01 | 0.1327 |
2196 | FAT2 | P11T-E | Human | Esophagus | ESCC | 8.43e-21 | 1.42e+00 | 0.1426 |
2196 | FAT2 | P12T-E | Human | Esophagus | ESCC | 3.84e-05 | 2.04e-01 | 0.1122 |
2196 | FAT2 | P15T-E | Human | Esophagus | ESCC | 2.72e-16 | 5.19e-01 | 0.1149 |
2196 | FAT2 | P16T-E | Human | Esophagus | ESCC | 9.67e-08 | 4.34e-02 | 0.1153 |
2196 | FAT2 | P17T-E | Human | Esophagus | ESCC | 1.92e-09 | 4.10e-01 | 0.1278 |
2196 | FAT2 | P20T-E | Human | Esophagus | ESCC | 3.25e-10 | 1.96e-01 | 0.1124 |
2196 | FAT2 | P21T-E | Human | Esophagus | ESCC | 8.42e-17 | 3.28e-01 | 0.1617 |
2196 | FAT2 | P22T-E | Human | Esophagus | ESCC | 5.23e-26 | 5.14e-01 | 0.1236 |
2196 | FAT2 | P23T-E | Human | Esophagus | ESCC | 8.45e-05 | 1.18e-01 | 0.108 |
2196 | FAT2 | P24T-E | Human | Esophagus | ESCC | 1.23e-04 | 2.78e-01 | 0.1287 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00315898 | Cervix | CC | cell-substrate adhesion | 96/2311 | 363/18723 | 1.48e-13 | 8.85e-11 | 96 |
GO:009013210 | Cervix | CC | epithelium migration | 90/2311 | 360/18723 | 2.45e-11 | 6.11e-09 | 90 |
GO:00016679 | Cervix | CC | ameboidal-type cell migration | 110/2311 | 475/18723 | 2.66e-11 | 6.36e-09 | 110 |
GO:001063110 | Cervix | CC | epithelial cell migration | 89/2311 | 357/18723 | 3.72e-11 | 8.54e-09 | 89 |
GO:009013010 | Cervix | CC | tissue migration | 90/2311 | 365/18723 | 5.42e-11 | 1.05e-08 | 90 |
GO:003158919 | Esophagus | ESCC | cell-substrate adhesion | 221/8552 | 363/18723 | 3.06e-09 | 6.62e-08 | 221 |
GO:000166720 | Esophagus | ESCC | ameboidal-type cell migration | 250/8552 | 475/18723 | 1.22e-03 | 5.97e-03 | 250 |
GO:001063120 | Esophagus | ESCC | epithelial cell migration | 187/8552 | 357/18723 | 6.05e-03 | 2.23e-02 | 187 |
GO:009013220 | Esophagus | ESCC | epithelium migration | 188/8552 | 360/18723 | 6.96e-03 | 2.54e-02 | 188 |
GO:009013020 | Esophagus | ESCC | tissue migration | 190/8552 | 365/18723 | 7.91e-03 | 2.82e-02 | 190 |
GO:003158917 | Oral cavity | OSCC | cell-substrate adhesion | 193/7305 | 363/18723 | 2.48e-08 | 4.82e-07 | 193 |
GO:000166719 | Oral cavity | OSCC | ameboidal-type cell migration | 228/7305 | 475/18723 | 3.46e-05 | 3.10e-04 | 228 |
GO:001063118 | Oral cavity | OSCC | epithelial cell migration | 174/7305 | 357/18723 | 1.04e-04 | 7.70e-04 | 174 |
GO:009013218 | Oral cavity | OSCC | epithelium migration | 175/7305 | 360/18723 | 1.18e-04 | 8.54e-04 | 175 |
GO:009013018 | Oral cavity | OSCC | tissue migration | 176/7305 | 365/18723 | 1.92e-04 | 1.29e-03 | 176 |
GO:003158918 | Oral cavity | LP | cell-substrate adhesion | 111/4623 | 363/18723 | 5.94e-03 | 3.53e-02 | 111 |
GO:003158920 | Skin | AK | cell-substrate adhesion | 74/1910 | 363/18723 | 4.40e-09 | 3.30e-07 | 74 |
GO:001063124 | Skin | AK | epithelial cell migration | 70/1910 | 357/18723 | 5.88e-08 | 2.95e-06 | 70 |
GO:009013224 | Skin | AK | epithelium migration | 70/1910 | 360/18723 | 8.28e-08 | 3.89e-06 | 70 |
GO:009013024 | Skin | AK | tissue migration | 70/1910 | 365/18723 | 1.45e-07 | 6.29e-06 | 70 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FAT2 | SNV | Missense_Mutation | novel | c.7839N>G | p.Asp2613Glu | p.D2613E | Q9NYQ8 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-CV-7411-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAT2 | SNV | Missense_Mutation | novel | c.12289N>T | p.Ala4097Ser | p.A4097S | Q9NYQ8 | protein_coding | tolerated(0.69) | benign(0.006) | TCGA-CV-7568-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAT2 | SNV | Missense_Mutation | novel | c.3302N>G | p.Ser1101Cys | p.S1101C | Q9NYQ8 | protein_coding | deleterious(0.02) | possibly_damaging(0.792) | TCGA-CV-7568-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAT2 | SNV | Missense_Mutation | novel | c.1910N>T | p.Ser637Phe | p.S637F | Q9NYQ8 | protein_coding | deleterious(0.05) | benign(0.007) | TCGA-CV-7568-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FAT2 | SNV | Missense_Mutation | rs377736336 | c.8777C>T | p.Ala2926Val | p.A2926V | Q9NYQ8 | protein_coding | tolerated(0.45) | benign(0.003) | TCGA-CV-A45O-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
FAT2 | SNV | Missense_Mutation | novel | c.9562N>T | p.Arg3188Cys | p.R3188C | Q9NYQ8 | protein_coding | tolerated(0.18) | benign(0.015) | TCGA-CV-A468-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
FAT2 | SNV | Missense_Mutation | rs759671829 | c.10535N>T | p.Ser3512Leu | p.S3512L | Q9NYQ8 | protein_coding | tolerated(0.05) | probably_damaging(0.968) | TCGA-CV-A6K2-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
FAT2 | SNV | Missense_Mutation | novel | c.3290G>T | p.Arg1097Leu | p.R1097L | Q9NYQ8 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-D6-6823-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
FAT2 | SNV | Missense_Mutation | novel | c.1668N>G | p.Asn556Lys | p.N556K | Q9NYQ8 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-D6-A4ZB-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
FAT2 | SNV | Missense_Mutation | rs374282108 | c.1129C>T | p.Pro377Ser | p.P377S | Q9NYQ8 | protein_coding | deleterious(0.03) | possibly_damaging(0.763) | TCGA-D6-A74Q-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |